Biotech entrepreneurs at Duke University recently sold their startup, Element Genomics, to a global pharmaceutics company. UCB has acquired the firm for $30 million. All four founders - Charlie Gershbach, Greg Crawford, Tim Reddy and Kris Wood - are members of the Duke Center for Genomic and Computational Biology.
Read More
